TY - JOUR
T1 - Dopamine D-histamine H receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway
AU - Moreno, Estefanía
AU - Hoffmann, Hanne
AU - Gonzalez-Sepúlveda, Marta
AU - Navarro, Gemma
AU - Casadó, Vicent
AU - Cortés, Antoni
AU - Mallol, Josefa
AU - Vignes, Michel
AU - McCormick, Peter J.
AU - Canela, Enric I.
AU - Lluís, Carme
AU - Moratalla, Rosario
AU - Ferré, Sergi
AU - Ortiz, Jordi
AU - Franco, Rafael
PY - 2011/2/18
Y1 - 2011/2/18
N2 - Previously, using artificial cell systems, we identified receptor heteromers between the dopamine D or D receptors and the histamine H receptor. In addition, we demonstrated two biochemical characteristics of the dopamine D receptor-histamine H receptor heteromer. We have now extended this work to show the dopamine D receptor-histamine H receptor heteromer exists in the brain and serves to provide a novel link between the MAPK pathway and the GABAergic neurons in the direct striatal efferent pathway. Using the biochemical characteristics identified previously, we found that the ability of H receptor activation to stimulate p44 and p42 extracellular signal-regulated MAPK (ERK 1/2) phosphorylation was only observed in striatal slices of mice expressing D receptors but not in D receptor-deficient mice. On the other hand, the ability of both D and H receptor antagonists to block MAPK activation induced by either D or H receptor agonists was also found in striatal slices. Taken together, these data indicate the occurrence of D -H receptor complexes in the striatum and, more importantly, that H receptor agonist-induced ERK 1/2 phosphorylation in striatal slices is mediated by D-H receptor heteromers. Moreover, H receptor-mediated phospho-ERK 1/2 labeling co-distributed with D receptor-containing but not with D receptor-containing striatal neurons. These results indicate that D -H receptor heteromers work as processors integrating dopamine- and histamine-related signals involved in controlling the function of striatal neurons of the direct striatal pathway.
AB - Previously, using artificial cell systems, we identified receptor heteromers between the dopamine D or D receptors and the histamine H receptor. In addition, we demonstrated two biochemical characteristics of the dopamine D receptor-histamine H receptor heteromer. We have now extended this work to show the dopamine D receptor-histamine H receptor heteromer exists in the brain and serves to provide a novel link between the MAPK pathway and the GABAergic neurons in the direct striatal efferent pathway. Using the biochemical characteristics identified previously, we found that the ability of H receptor activation to stimulate p44 and p42 extracellular signal-regulated MAPK (ERK 1/2) phosphorylation was only observed in striatal slices of mice expressing D receptors but not in D receptor-deficient mice. On the other hand, the ability of both D and H receptor antagonists to block MAPK activation induced by either D or H receptor agonists was also found in striatal slices. Taken together, these data indicate the occurrence of D -H receptor complexes in the striatum and, more importantly, that H receptor agonist-induced ERK 1/2 phosphorylation in striatal slices is mediated by D-H receptor heteromers. Moreover, H receptor-mediated phospho-ERK 1/2 labeling co-distributed with D receptor-containing but not with D receptor-containing striatal neurons. These results indicate that D -H receptor heteromers work as processors integrating dopamine- and histamine-related signals involved in controlling the function of striatal neurons of the direct striatal pathway.
UR - http://www.scopus.com/inward/record.url?scp=79953141056&partnerID=8YFLogxK
U2 - 10.1074/jbc.M110.161489
DO - 10.1074/jbc.M110.161489
M3 - Article
AN - SCOPUS:79953141056
VL - 286
SP - 5846
EP - 5854
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 7
ER -